RPRC1 inhibitors are a class of small molecules that have gained significant attention in the field of molecular biology and cellular research due to their unique ability to selectively target a specific protein known as RPRC1. These inhibitors are designed to modulate the activity of RPRC1, a crucial protein involved in various cellular processes, without affecting other cellular components. The term "RPRC1" stands for "Regulator of Proliferation, Replication, and Cell Cycle 1," highlighting its multifunctional role within the cell.
Chemically, RPRC1 inhibitors are typically organic compounds characterized by their specific structural features that allow them to interact with the binding sites or active regions of RPRC1. Through this interaction, these inhibitors can either block or enhance the functions of RPRC1, depending on the specific mechanism of action. Their mode of action often involves binding to specific amino acid residues or domains within the protein, disrupting protein-protein interactions, or altering the protein's conformation, ultimately affecting its activity. Researchers use RPRC1 inhibitors as valuable tools to dissect the intricate cellular pathways and signaling cascades in which RPRC1 is involved.In summary, RPRC1 inhibitors represent a chemically diverse class of compounds designed to modulate the activity of the RPRC1 protein. Their precise mechanisms of action can vary, but they all share the common goal of selectively influencing RPRC1-related cellular processes. These inhibitors are indispensable tools in cell biology research, allowing scientists to unravel the complexities of cell cycle regulation, DNA replication, and proliferation pathways.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Inhibits mTOR (mammalian target of rapamycin) signaling, preventing cell growth and proliferation. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $25.00 $117.00 $209.00 | 27 | |
Targets the BCR-ABL kinase. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $62.00 $112.00 $214.00 $342.00 | 74 | |
Inhibits the EGFR kinase, used by blocking tumor cell growth. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $56.00 $260.00 $416.00 | 129 | |
Targets multiple kinases, including RAF, VEGFR, and PDGFR, to inhibit angiogenesis | ||||||
Everolimus | 159351-69-6 | sc-218452 sc-218452A | 5 mg 50 mg | $128.00 $638.00 | 7 | |
Inhibits mTOR, reducing cell proliferation and angiogenesis | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $47.00 $145.00 | 51 | |
Targets multiple kinases, including BCR-ABL and SRC family kinases | ||||||
MDV3100 | 915087-33-1 | sc-364354 sc-364354A | 5 mg 50 mg | $240.00 $1030.00 | 7 | |
Blocks the androgen receptor. | ||||||
Olaparib | 763113-22-0 | sc-302017 sc-302017A sc-302017B | 250 mg 500 mg 1 g | $206.00 $299.00 $485.00 | 10 | |
Inhibits PARP enzymes, studied in the research of BRCA-mutated | ||||||
ABT-199 | 1257044-40-8 | sc-472284 sc-472284A sc-472284B sc-472284C sc-472284D | 1 mg 5 mg 10 mg 100 mg 3 g | $116.00 $330.00 $510.00 $816.00 $1632.00 | 10 | |
Targets BCL-2 proteins. | ||||||
Ibrutinib | 936563-96-1 | sc-483194 | 10 mg | $153.00 | 5 | |
Targets BTK (Bruton's tyrosine kinase), used in B-cell malignancies to disrupt signaling and cell survival. | ||||||